ResearcherTongji UniversityActive in the last 2 years
Huixiao Yuan
Matched on ORCID iD 0009-0006-1768-7947; OpenAlex author ID A5076899927. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Corrigendum to "SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression" [Biomed. Pharmacoth… Co-author DOI 10.1016/j.biopha.2026.119363↗
- SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression. Co-author DOI 10.1016/j.biopha.2022.112672↗
- Solute Carrier Family 35 Member F2 Regulates Cisplatin Resistance and Promotes Malignant Progression of Pancreatic Cancer by Regulating RNA Binding Motif Prote… Co-author DOI 10.1155/2022/5091154↗
- Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/2211-5463.12741↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bingdi Chen · 2 shared papers, 2022–2026 · strength 0.41
- Paper Corrigendum to "SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of C… DOI 10.1016/j.biopha.2026.119363↗
- Paper SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA express… DOI 10.1016/j.biopha.2022.112672↗
- Shuxian Zhang · 3 shared papers, 2019–2022 · strength 0.40
- Paper Solute Carrier Family 35 Member F2 Regulates Cisplatin Resistance and Promotes Malignant Progression of Pancreatic Canc… DOI 10.1155/2022/5091154↗
- Paper SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA express… DOI 10.1016/j.biopha.2022.112672↗
- Paper Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarc… DOI 10.1002/2211-5463.12741↗
- Qingqing Li · 2 shared papers, 2019–2022 · strength 0.26
- Paper Solute Carrier Family 35 Member F2 Regulates Cisplatin Resistance and Promotes Malignant Progression of Pancreatic Canc… DOI 10.1155/2022/5091154↗
- Paper Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarc… DOI 10.1002/2211-5463.12741↗
- Hua Jiang · 2 shared papers, 2019–2022 · strength 0.23
- Paper SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA express… DOI 10.1016/j.biopha.2022.112672↗
- Paper Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarc… DOI 10.1002/2211-5463.12741↗
- Hua Jiang · 1 shared paper, 2022 · strength 0.16
- Xin Huang · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.